Literature DB >> 20574961

Biointeraction analysis of carbamazepine binding to alpha1-acid glycoprotein by high-performance affinity chromatography.

Hai Xuan1, K S Joseph, Chunling Wa, David S Hage.   

Abstract

Interactions of the drug carbamazepine with the serum protein alpha(1)-acid glycoprotein (AGP) were examined by high-performance affinity chromatography. Frontal analysis studies with an immobilized AGP column and control column indicated carbamazepine had both low-affinity interactions with the support and high-affinity interactions with AGP. When a correction was made for binding to the support, the association equilibrium constant measured at pH 7.4 and 37 degrees C for carbamazepine with AGP was 1.0 (+/-0.1) x 10(5) M(-1), with values that ranged from 5.1 to 0.58 x 10(5) M(-1) in going from 5 to 45 degrees C. It was found in competition studies that these interactions were occurring at the same site that binds propranolol on AGP. Temperature studies indicated that the change in enthalpy was the main driving force for the binding of carbamazepine to AGP. These results provide a more complete picture of how carbamazepine binds to AGP in serum. This report also illustrates how high-performance affinity chromatography can be used to examine biological interactions and drug-protein binding in situations in which significant interactions for an analyte are present with both the chromatographic support and an immobilized ligand.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20574961      PMCID: PMC3442790          DOI: 10.1002/jssc.201000214

Source DB:  PubMed          Journal:  J Sep Sci        ISSN: 1615-9306            Impact factor:   3.645


  19 in total

1.  In vitro binding of propranolol and progesterone to native and desialylated human orosomucoid.

Authors:  A K Wong; J C Hsia
Journal:  Can J Biochem Cell Biol       Date:  1983-10

2.  Immobilized serum albumin: rapid HPLC probe of stereoselective protein-binding interactions.

Authors:  E Domenici; C Bertucci; P Salvadori; S Motellier; I W Wainer
Journal:  Chirality       Date:  1990       Impact factor: 2.437

3.  In vivo binding characteristics of carbamazepine and carbamazepine 10, 11-epoxide to serum proteins in monotherapy adult patients.

Authors:  Y Kodama; M Kuranari; K Tsutsumi; T Okamoto; H Kodama; F Yasunaga; I Fujii; M Takeyama
Journal:  Int J Clin Pharmacol Ther       Date:  1994-11       Impact factor: 1.366

4.  Analysis of drug interactions with high-density lipoprotein by high-performance affinity chromatography.

Authors:  Sike Chen; Matthew R Sobansky; David S Hage
Journal:  Anal Biochem       Date:  2009-10-13       Impact factor: 3.365

Review 5.  Clinical pharmacokinetics of carbamazepine.

Authors:  L Bertilsson
Journal:  Clin Pharmacokinet       Date:  1978 Mar-Apr       Impact factor: 6.447

6.  Determinants of carbamazepine and carbamazepine 10,11-epoxide binding to serum protein, albumin and alpha 1-acid glycoprotein.

Authors:  J J MacKichan; E M Zola
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

7.  Development of dihydrazide-activated silica supports for high-performance affinity chromatography.

Authors:  P F Ruhn; S Garver; D S Hage
Journal:  J Chromatogr A       Date:  1994-05-27       Impact factor: 4.759

8.  Characterization of a common binding site for basic drugs on human alpha 1-acid glycoprotein (orosomucoid).

Authors:  W E Müller; A E Stillbauer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-03       Impact factor: 3.000

9.  Effect of the sialylation state of alpha 1-acid glycoprotein on propranolol binding.

Authors:  S Primozic; P J McNamara
Journal:  J Pharm Sci       Date:  1985-04       Impact factor: 3.534

10.  Alpha 1-acid glycoprotein concentration and serum protein binding of carbamazepine and carbamazepine-10,11 epoxide in children with epilepsy.

Authors:  M Contin; R Riva; F Albani; E Perucca; G Lamontanara; A Baruzzi
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

View more
  19 in total

1.  Calculation of normalized drug concentrations in the presence of altered plasma protein binding.

Authors:  Florin Marcel Musteata
Journal:  Clin Pharmacokinet       Date:  2012-01-01       Impact factor: 6.447

Review 2.  Pharmaceutical and biomedical applications of affinity chromatography: recent trends and developments.

Authors:  David S Hage; Jeanethe A Anguizola; Cong Bi; Rong Li; Ryan Matsuda; Efthimia Papastavros; Erika Pfaunmiller; John Vargas; Xiwei Zheng
Journal:  J Pharm Biomed Anal       Date:  2012-01-14       Impact factor: 3.935

Review 3.  Analysis of solute-protein interactions and solute-solute competition by zonal elution affinity chromatography.

Authors:  Pingyang Tao; Saumen Poddar; Zuchen Sun; David S Hage; Jianzhong Chen
Journal:  Methods       Date:  2018-02-02       Impact factor: 3.608

Review 4.  High performance affinity chromatography and related separation methods for the analysis of biological and pharmaceutical agents.

Authors:  Chenhua Zhang; Elliott Rodriguez; Cong Bi; Xiwei Zheng; Doddavenkatana Suresh; Kyungah Suh; Zhao Li; Fawzi Elsebaei; David S Hage
Journal:  Analyst       Date:  2018-01-15       Impact factor: 4.616

Review 5.  Analysis of stereoselective drug interactions with serum proteins by high-performance affinity chromatography: A historical perspective.

Authors:  Zhao Li; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2017-01-11       Impact factor: 3.935

6.  Development of affinity microcolumns for drug-protein binding studies in personalized medicine: interactions of sulfonylurea drugs with in vivo glycated human serum albumin.

Authors:  Jeanethe Anguizola; K S Joseph; Omar S Barnaby; Ryan Matsuda; Guadalupe Alvarado; William Clarke; Ronald L Cerny; David S Hage
Journal:  Anal Chem       Date:  2013-04-17       Impact factor: 6.986

7.  Entrapment of alpha1-acid glycoprotein in high-performance affinity columns for drug-protein binding studies.

Authors:  Cong Bi; Abby Jackson; John Vargas-Badilla; Rong Li; Giana Rada; Jeanethe Anguizola; Erika Pfaunmiller; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-11-27       Impact factor: 3.205

8.  Research in bioanalysis and separations at the University of Nebraska - Lincoln.

Authors:  David S Hage; Eric D Dodds; Liangcheng Du; Robert Powers
Journal:  Bioanalysis       Date:  2011-05       Impact factor: 2.681

Review 9.  Analysis of biomolecular interactions using affinity microcolumns: a review.

Authors:  Xiwei Zheng; Zhao Li; Sandya Beeram; Maria Podariu; Ryan Matsuda; Erika L Pfaunmiller; Christopher J White; NaTasha Carter; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-01-27       Impact factor: 3.205

10.  Analysis of free drug fractions in serum by ultrafast affinity extraction and two-dimensional affinity chromatography using α1-acid glycoprotein microcolumns.

Authors:  Cong Bi; Xiwei Zheng; David S Hage
Journal:  J Chromatogr A       Date:  2016-01-04       Impact factor: 4.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.